This activity is specifically designed for:
Public Health Professionals
Regulators
Decision Makers and Policy Makers
At the end of the course, learners should be able to:
Describe the current situation regarding COVID-19 testing in Africa
Explain the characteristics of antigen rapid diagnostic tests
Identify innovative testing and prevention strategies that support reopening economies
The purpose of this activity is to present examples of how rapid antigen tests are being used as a diagnostic tool to confirm the clinical diagnosis of patients with symptoms consistent with COVID-19, and as a public health tool for screening of asymptomatic populations to ensure COVID-safe environments in schools, workplaces and mass gatherings for religious, sports and cultural activities. The agenda is as follows:
Antigen Rapid Diagnostic Test (Ag-RDT) Rollout in Africa
Ag-RDT Performance and Operational Characteristics
Use of Ag-RDT for Symptomatic Patients
Case Study: Cameroon Uses Ag-RDTs to Limit the Socio-economic Impact of COVID-19
Use of Ag-RDT for Schools, Workplaces
Use of Ag-RDT for Mass Gatherings
Perspectives on COVID-19 Antigen Testing
Professor Rosanna Peeling and Professor David Heymann are Co-directors for the course.
Professor Rosanna Peeling, International Diagnostics Centre, London School of Hygiene and Tropical Medicine
Professor David Heymann, London School of Hygiene and Tropical Medicine
Dr. Abebaw Kebede, Africa Centres for Disease Control and Prevention
Professor Yap Boum II, Africa for Epicentre, Médecins sans Frontières
Dr. Noah Fongwen, London School of Hygiene and Tropical Medicine & Africa Centres for Disease Control and Prevention
Dr. Yenew Kebede Tebeja, Africa Centres for Disease Control and Prevention
Add your email to the mailing list to get the latest updates.
